WELLINTA 150 MG SR (?BUPROPION ) 30 FILM-COATED TABLETS

PRODUCT DETAILS

Bupropion is The only dual acting antidepressant available targeting norepinephrine and dopamine neurotransmitter approved

for treatment of depression & Seasonal affective disorder?s

Bupropion exerts its effect primarily through the inhibition of dopamine reuptake into neuronal synaptic vesicles. It is also a weak

noradrenalin reuptake inhibitor and has no effect on the serotonin system.

Bupropion is licensed for smoking cessation in both the UK and US and is recommended as a first line agent for smoking cessation

(NICE 2002). Approximately 1 in 5 smokers successfully stop and remain non-smoking at one year with bupropion therapy

Product Composition:

The first and the only generic of Bupropion in the Egyptian Market.